The Ramsay (ASX:RHC) share price lifted 8% last time the company reported

Let's take a look.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The S&P/ASX 200 Index (ASX: XJO) is enjoying a decent day of trading this Wednesday. The ASX 200 is currently up 0.16% to 7,515 points at the time of writing. However, in what might be some trepidation about it's earnings report tomorrow, the Ramsay Health Care Limited (ASX: RHC) share price is not enjoying the same treatment. Ramsay shares are currently trading at the rather unfortunate share price of  $66.66, down 0.48% for the day.

So as I just mentioned, Ramsay is scheduled to report its full-year earnings for FY2021 tomorrow morning. But while we wait with bated breath for these numbers, let's check out what the Ramsay Health Care share price did last time the company had an appointment with its investors.

So Ramsay reported its half-year earnings back in February of this year, 25 February to be precise.

Here's a summary of what the company reported at the time:

  • Revenues of $5.9 billion, a 6.6% fall over the previous corresponding period (pcp).
  • Statutory net profit of $226 million, a 12.5% drop over the pcp.
  • Diluted earnings per share (EPS) came in at 96.9 cents, a decline of 21.1% over the pcp
  • Earnings before interest and tax (EBIT) of $583.8 million, a 4.2% slump.
  • An interim dividend of 48.5 cents per share, fully franked, 21.1% lower than Ramsay's previous interim payout.
share price up

Image source: Getty Images

How did the Ramsay Health Care share price respond?

Despite these numbers showing a significant hit from the coronavirus outbreak, investors responded enthusiastically to these earnings back in February. As we covered at the time, investors sent Ramsay shares up around 8% in the first few hours of trading following this release. As it stands today, Ramsay shares are around 5.5% higher than the day before this report became public 6 months ago.

At the current Ramsay share price, the company has a market capitalisation of $15.32 billion, a price-to-earnings (P/E) ratio of 62.96 and a dividend yield of 0.72%.

This company is up 6.88% year to date in 2021 so far, but is only up 1.07% over the past 12 months. Disappointingly for its investors, the Ramsay share price is also down close to 12% over the past 5 years.

Motley Fool contributor Sebastian Bowen owns shares of Ramsay Health Care Limited. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Ramsay Health Care Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Healthcare Shares

A group of people in a corporate setting do a collective high five.
Healthcare Shares

Up 1,173% in a year, what do 4DMedical shares have over other healthcare stocks?

Expert explains why 4DMedical is somewhat sheltered from today's sector headwinds.

Read more »

A couple sits on the bed in their hotel room wearing white robes, both have seen the bad news on their phones.
Earnings Results

What's going on with ResMed shares today?

The sleep disorder treatment company has released its third-quarter update this morning.

Read more »

A young man sits at his desk working on his laptop with a big smile on his face.
Healthcare Shares

Resmed reports double-digit revenue and profit increases in Q3 FY26

Resmed posted double-digit revenue and profit growth in Q3 FY26, with management confident about continued momentum.

Read more »

a woman puts her fingers in her ears with a pained expression on her face with her eyes closed as though trying to block hearing bad news or an unpleasant loud noise.
Healthcare Shares

Cochlear shares crashed in April, but is a comeback looming?

This ASX 200 healthcare stock is caught between short-term pain and long-term potential.

Read more »

A medical researcher rests his forehead on his fist with a dejected look on his face while sitting behind a scientific microscope with another researcher's hand on his shoulder, as if giving comfort.
Healthcare Shares

What's making healthcare the worst sector on the ASX 200, down 39% in a year?

An expert outlines the key headwinds weighing on the industry and share prices today.

Read more »

woman testing substance in laboratory dish, csl share price
Healthcare Shares

Good news, falling shares: What's dragging this ASX stock lower?

In biotech, strong updates don't always push the share price higher.

Read more »

A graphic showing a businessman running up a white upwards rising arrow symbolising the soaring Magellan share price today
Healthcare Shares

Guess which ASX All Ords healthcare share is rocketing 18% in Thursday's sinking market

Investors are piling into the ASX healthcare share on Thursday. But why?

Read more »

A woman sits at her computer with her chin resting on her hand as she contemplates her next potential investment.
Healthcare Shares

Mesoblast shares: Cash burn falls and Ryoncil® sales climb

Mesoblast reports higher Ryoncil® sales, improved cash management, and research milestones for the March 2026 quarter.

Read more »